China urges companies to ensure COVID-related medical supplies
BEIJING, Dec 15 (Reuters) - China has urged state-backed
pharmaceuticals giants to ensure provision of COVID-related
medical supplies, the country's state asset regulator said on
Thursday.
The companies include China Resources, China General
Technology and Sinopharm, which own businesses that produce
medications that could ease coronavirus symptoms.
(Reporting by Ella Cao and Meg Shen
Editing by David Goodman)
((Ella.Cao@thomsonreuters.com;))
Recent news on Sinopharm
See all newsBrief: Sinopharm Group Says 9M Sinopharm Accord Net Income Attributable RMB952.5 Million (Oct 20)
Medical products distributor Sinopharm Group's prelim 9-month revenue slips
Brief: BlackRock's Long Position In H Shares Of Sinopharm Reduces To 9.23% On Oct 13, HKEX Shows
Sinopharm interim revenue edges down on softness in pharmaceutical distribution business
Brief: Sinopharm Group To Sell 30.13% Stake In China National Medicines Guorui Pharmaceutical For